Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3/A Insider 3/A
  5. 4 Grant or award CFO acquired 50,000 shares (grant or award)
  6. 4 Grant or award Director acquired 100,000 shares (grant or award)
  7. 4 Grant or award Chief Operating Officer acquired 800,000 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market buy See Remarks bought 200,000 shares at an average $0.05 ($10,792)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Other acquisition Interim CEO, CFO, COO acquired 266,666 shares (code O)
  19. 4 Other acquisition Chief Technology Officer acquired 306,947 shares (code O)
  20. 4 Other acquisition Director acquired 200,000 shares (code O)

Page 9 of 19 · 367 filings